HASKREVO Trademark

Trademark Overview

On Friday, April 26, 2019, a trademark application was filed for HASKREVO with the United States Patent and Trademark Office. The USPTO has given the HASKREVO trademark a serial number of 88404759. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Gilead Sciences Ireland UC. The HASKREVO trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis
haskrevo

General Information

Serial Number88404759
Word MarkHASKREVO
Filing DateFriday, April 26, 2019
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6976519
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Monday, January 9, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, January 6, 2023NOTICE OF ALLOWANCE CANCELLED
Friday, January 6, 2023TEAS DELETE 1(B) BASIS RECEIVED
Thursday, July 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 13, 2022SOU EXTENSION 5 GRANTED
Wednesday, June 29, 2022SOU EXTENSION 5 FILED
Wednesday, July 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 29, 2022TEAS EXTENSION RECEIVED
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2022SOU EXTENSION 4 GRANTED
Thursday, January 20, 2022SOU EXTENSION 4 FILED
Thursday, January 20, 2022TEAS EXTENSION RECEIVED
Wednesday, July 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021SOU EXTENSION 3 GRANTED
Monday, July 12, 2021SOU EXTENSION 3 FILED
Monday, July 12, 2021TEAS EXTENSION RECEIVED
Thursday, December 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 22, 2020SOU EXTENSION 2 GRANTED
Tuesday, December 22, 2020SOU EXTENSION 2 FILED
Tuesday, December 22, 2020TEAS EXTENSION RECEIVED
Saturday, June 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020SOU EXTENSION 1 GRANTED
Thursday, June 25, 2020SOU EXTENSION 1 FILED
Thursday, June 25, 2020TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2019ASSIGNED TO LIE
Friday, November 8, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 15, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019SUSPENSION LETTER WRITTEN
Monday, July 8, 2019ASSIGNED TO EXAMINER
Thursday, May 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 30, 2019NEW APPLICATION ENTERED

Related Keywords

haskrevo preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney